DERIVATIVES OF PHYSIOLOGICALLY ACTIVE SUBSTANCE K-252
    1.
    发明公开
    DERIVATIVES OF PHYSIOLOGICALLY ACTIVE SUBSTANCE K-252 失效
    DERIVATE DES PHYSIOLOGISCH AKTIVEN MITTELS K-252。

    公开(公告)号:EP0303697A1

    公开(公告)日:1989-02-22

    申请号:EP87901672.3

    申请日:1987-03-09

    IPC分类号: C07D498/22 A61K31/55

    CPC分类号: C07D498/22

    摘要: Novel derivatives of K-252 ((8R', 9S*, 11S')-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo[a,g]cycloocta[cde]trinden-1-one) represented by formula (l) (wherein W 1 , W 2 , R 1 , R 2 , R 3 , R 4 , X, and Y represent various substituents) are disclosed. These compounds are physiologically active substances having a protein kinase C-inhibiting activity and an oncostatic activity, thus being useful as medicines.

    摘要翻译: 抗生素K-252衍生物。 式(I)的化合物是新的:在(I)中,R 1和R 3是OH,低级烷氧基或氨基,或R 3是H,R 1是H,Me,OH,Br,Cl,羟甲基,NR 5 R 6等; R2是H或氨基; 一个或R 5 / R 6是H,另一个是H,氨基甲酰基或低级烷基氨基羰基,或者R 5和R 6都是低级烷基; R4是H,C1,氨基甲酰基,低级烷基,氨基或-CH2CH2R7; R7是Br,氨基,羟基,二(低级烷基)氨基或羟基。 低级烷基氨基; W1和W2为H或一起为= O; X是H,甲酰基,低级烷氧基羰基,-CONR 8 R 9,-CH 2 A或-CH = NR 12; R8和R9是H,低级烷基,羟基。 低级烷基或R8是H,R9是OH; A是OH,叠氮基,低级烷硫基,低级烷基磺酰基,-NR10R11,-N = CHNMe2,-OCOCH2CH2COOH或2-四氢吡喃基氧基; R10和R11都是H或一个是H,低级烷基,芳基,羧基 - 低级烷基等,xycar,另一个是低级烷基(选择C1-substd)。 或R 10和R 11一起为-CH 2 CH 2 -B-CH 2 CH 2 - ; B是亚甲基,-NH-,S或O; R 12是OH,氨基,胍基或2-咪唑基氨基; Y是OH或氨基甲酰氧基; X和Y可以是(-XY-)-O-,-CH2O-,-CH2OCOO-,-CH2-O-CS-O-,-CH2-NR13-COO-,-CH2-N = CR14-O- 或-CH 2 -NH-CS-O-CH 2 -O-SO-O-; R 13是H,低级烷基,芳基,甲酰基甲基,-CH 2 CHOH-CH 2 OH或-CH 2 CH = N-NH-C(= NH)-NH 2; R 14是低级烷基或低级烷硫基。 当W1 / W2 = 0时,R1 = R2 = R3 = H; 当R 4为低级烷基时,氨基或-CH 2 CH 2 R 7,则W1 / W2为= O。 当Y是氨基甲酰氧基时,R1 = R2 = R3 = W1 = W2 = H,R4是氨基甲酰基,X是低级烷氧基羰基。 当R4为C1时,R1 = R2 = R3 = W1 = W2 = H,X为低级烷氧基羰基。 当X是H,甲酰基,-CONR 8 R 9,-CH 2 A或-CH = NR 12时,则R1 = R2 = R3 = W1 = W2 = R4 = H。 当X是-CONHOH时,则R1 = R2 = R3 = R4 = H。 = R4 = H。